MANILA, Philippines — Chinese drug Lianhua Qingwen is still considered a prescription medicine, Food and Drug Administration (FDA) Director-General Eric Domingo clarified Thursday.
“It is still a prescription medicine. But a regular doctor’s prescription will do. No more S2 prescription needed,” Domingo told INQUIRER.net in a text message.
In an earlier House health committee briefing, Domingo said the Chinese medicine was recently delisted by the Dangerous Drugs Board (DDB) as a dangerous substance.
This means the patient does not need an S2 prescription to purchase it.
An S2 prescription can only be issued by a physician with an S2 license from the Philippine Drug Enf…
Keep on reading: Chinese drug ‘Lianhua Qingwen’ still a prescription medicine — FDA chief